Literature DB >> 20164430

Cutting edge: polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells.

Yaming Wang1, Marina Cella, Susan Gilfillan, Marco Colonna.   

Abstract

Polyinosinic:polycytidylic acid (poly I:C), a synthetic analog of double-stranded viral RNA, serves as a potent adjuvant for vaccination against soluble proteins, pathogens, and tumors. Poly I:C is sensed by both TLR3 in the endosomes and melanoma differentiation-associated protein 5 (MDA5) in the cytoplasm. Although it is known that TLR3 is required for cross-priming of CD8 T cells specific for viral Ags, the role of MDA5 in inducing CD8 T cell responses is still unclear. In this study, we demonstrate that in mice lacking MDA5, the majority of CD8 T cells do not survive after primary immunization with poly I:C and Ag, impairing memory response to subsequent Ag challenge. Furthermore, bone marrow chimera experiments revealed that MDA5 expression in radiation-resistant stromal cells, but not in radiation-sensitive hematopoietic cells, is essential for establishing CD8 T cell memory. We conclude that MDA5 and TLR3 mediate substantially distinct yet complementary functions during poly I:C-mediated activation of Ag-specific CD8 T cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164430     DOI: 10.4049/jimmunol.0903201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

2.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

3.  Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.

Authors:  Chrisann Kyi; Vladimir Roudko; Rachel Sabado; Yvonne Saenger; William Loging; John Mandeli; Tin Htwe Thin; Deborah Lehrer; Michael Donovan; Marshall Posner; Krzysztof Misiukiewicz; Benjamin Greenbaum; Andres Salazar; Philip Friedlander; Nina Bhardwaj
Journal:  Clin Cancer Res       Date:  2018-06-27       Impact factor: 12.531

4.  Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.

Authors:  José V Pérez-Girón; Alan Belicha-Villanueva; Ebrahim Hassan; Sergio Gómez-Medina; Jazmina L G Cruz; Anja Lüdtke; Paula Ruibal; Randy A Albrecht; Adolfo García-Sastre; César Muñoz-Fontela
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

Review 5.  Designing therapeutic cancer vaccines by mimicking viral infections.

Authors:  Hussein Sultan; Valentyna I Fesenkova; Diane Addis; Aaron E Fan; Takumi Kumai; Juan Wu; Andres M Salazar; Esteban Celis
Journal:  Cancer Immunol Immunother       Date:  2016-04-06       Impact factor: 6.968

6.  Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.

Authors:  Kathrin Kastenmüller; Ulrike Wille-Reece; Ross W B Lindsay; Lauren R Trager; Patricia A Darrah; Barbara J Flynn; Maria R Becker; Mark C Udey; Björn E Clausen; Botond Z Igyarto; Daniel H Kaplan; Wolfgang Kastenmüller; Ronald N Germain; Robert A Seder
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

Review 7.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 8.  Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.

Authors:  Man Yu; Stewart J Levine
Journal:  Cytokine Growth Factor Rev       Date:  2011-04-03       Impact factor: 7.638

9.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 10.  Peptide vaccines in cancer-old concept revisited.

Authors:  Takumi Kumai; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Curr Opin Immunol       Date:  2016-12-09       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.